KRH-1636 is a highly potent and selective oral CXCR4 antagonist that blocks X4-tropic HIV-1 entry and replication in vitro by inhibiting viral fusion and SDF-1alpha signaling. Its research applications include studying HIV pathogenesis, coreceptor tropism, and CXCR4-mediated cell migration in both cellular and animal models of infection and metastasis.
Molecular Weight:
551.68
CAS Number:
[568526-77-2]
Formula:
C32H37N7O2
Target:
Others,CXCR
* VAT and and shipping costs not included. Errors and price changes excepted
